The novel approach of the medication represents a major advance in the management of the condition. Distinct from existing drugs, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide515204.blogdal.com/42435113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment